Serum Inflammatory and Immune Mediators Are Elevated in Early Stage Diabetic Nephropathy.
Perlman, Alan S; Chevalier, James M; Wilkinson, Patrick; Liu, Hao; Parker, Thomas; Levine, Daniel M; Sloan, Betty Jo; Gong, Anna; Sherman, Raymond; Farrell, Francis X.
Ann Clin Lab Sci
; 45(3): 256-63, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26116588
Levels of heavy metals and their binding protein metallothionein in type 2 diabetics with kidney disease.
Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes.
MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
Angiopoietin-2, Renal Deterioration, Major Adverse Cardiovascular Events and All-Cause Mortality in Patients with Diabetic Nephropathy.
Understanding the epigenetic syntax for the genetic alphabet in the kidney.
Vasopressin and diabetic nephropathy.
Hepatocyte Nuclear Factor 1ß-Associated Kidney Disease: More than Renal Cysts and Diabetes.
Conceptos actuales sobre nefropatía diabética
Genetic and clinical variables identify predictors for chronic kidney disease in type 2 diabetes.